News

In a report released today, Andrew Mok CFA from Barclays maintained a Hold rating on Centene, with a price target of $45.00. The company’s shares closed last Friday at $28.39. Take advantage of ...
The S&P 500 was little changed on Monday, July 28, 2025, as investors absorbed the U.S.-EU trade deal and braced for this ...
Shares of health coverage company Centene (NYSE:CNC) fell 3% in the morning session after the company was downgraded by ...
Centene ( NYSE: CNC) has been downgraded to Neutral from Overweight at Cantor citing heightened uncertainty in the company's ...
Fintel reports that on July 28, 2025, Cantor Fitzgerald downgraded their outlook for Centene (NYSE:CNC) from Overweight to ...
CNC has offered FY2025 adj EPS range at between $1.25 (-82.5% YoY) and $1.75 (-75.5% YoY), as medical costs rise drastically ...
This downturn is primarily attributed to a continued increase in medical costs for government-backed insurance plans, ...
The managed-care company pointed to increased medical spending in Medicaid, due to behavioral health, home health and ...
Centene represents a countercyclical investment opportunity in managed care, as it can benefit from economic downturns through increasing enrollment in its Medicaid and individual exchange products.
On the post-earnings call with analysts, Chief Executive Sarah London said the current forecast for 2025 adjusted earnings per share, which excludes nonrecurring items, was $1.75. That was down from ...
Centene reported a Q2 loss and pulled its 2025 guidance despite rising revenue, citing higher healthcare costs and shifting ...
Analysts expect the Saint Louis, Missouri-based company to report quarterly earnings at 23 cents per share, down from $2.42 ...